Methylxanthines in COPD: yes to caffeine, no to theophylline
Eur Respir J
.
2021 Jun 10;57(6):2004564.
doi: 10.1183/13993003.04564-2020.
Print 2021 Jun.
Authors
Ken M Kunisaki
1
2
,
Don D Sin
3
Affiliations
1
Minneapolis VA Health Care System, Minneapolis, MN, USA
[email protected]
.
2
University of Minnesota, Minneapolis, MN, USA.
3
Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
PMID:
34112714
DOI:
10.1183/13993003.04564-2020
No abstract available
Publication types
Editorial
Research Support, U.S. Gov't, Non-P.H.S.
Comment
MeSH terms
Caffeine
Humans
Pulmonary Disease, Chronic Obstructive*
Theophylline*
Xanthines
Substances
Xanthines
methylxanthine
Caffeine
Theophylline